US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

111.47

-1.3900-1.23%

Volume:86.68K

Turnover:9.61M

Market Cap:1.64B

PE:-12.56

High:113.95

Open:109.23

Low:107.22

Close:112.86

52wk High:155.29

52wk Low:26.19

Shares:14.67M

Float Shares:8.64M

Volume Ratio:0.52

T/O Rate:1.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.8768

EPS(LYR):-9.0434

ROE:-1773.60%

ROA:-43.61%

PB:-30.87

PE(LYR):-12.33

Loading ...

Overview Company News Filings

Inhibrx Biosciences reports strong Phase 2 INBRX-106 data

Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million

Inhibrx Biosciences Shares Fall 22% After Co Releases Data from Mid-Stage Study of Its Experimental Combination Cancer Drug

THOMSON REUTERS

Analysts Offer Insights on NA Companies: First Horizon (FHN) and Inhibrx Biosciences Inc (INBX)

Inhibrx Biosciences Says Cancer Combination Therapy Shows Improved Response in Phase 2 Study

MT Newswires Live

Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment

Inhibrx Says Phase 2 Trial Shows INBRX-106 Plus Pembrolizumab Lifts Response Rate to 48.3% in HNSCC

Inhibrx Biosciences: Currently Conducting Phase 1/2 Study of Inbrx-106 in Perioperative Setting of Nsclc, with Initial Results Targeted by Mid-2027

THOMSON REUTERS

Inhibrx Biosciences Inc: Evaluating Potential of Inbrx-106 in Other Highly Immunogenic Tumor Types

THOMSON REUTERS

Inhibrx Biosciences - to Expand Phase 2 Study by 50 Hpv+ Patients

THOMSON REUTERS

Inhibrx Biosciences - Inbrx-106 Plus Pembrolizumab Achieves 48.3% Corr and 72.4% Six-Month Pfs Rate

THOMSON REUTERS

Inhibrx Biosciences Inc: Also Plans to Explore Potential of Inbrx-106 in Combination with Therapeutic Cancer Vaccines

THOMSON REUTERS

Inhibrx's Inbrx-106 Nearly Doubles Response Rate and Achieves Interim Median Pfs of 9.6 Months in Phase 2 Hnscc Study

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 07:25 Am

Inhibrx Schedules Sept. 8 Webcast to Release Phase 2 INBRX-106 First-Line HNSCC Study Endpoint Results

Inhibrx Biosciences Price Target Announced at $245.00/Share by HC Wainwright & Co.

Inhibrx Biosciences, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $245

THOMSON REUTERS

Inhibrx Biosciences (INBX) Earnings Put Its Valuation Back In Focus

Simply Wall St.

Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained

Inhibrx Falls on Wider-than-Expected Quarterly Loss

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/INBX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":111.47,"timestamp":1789053627524,"preClose":112.86,"halted":0,"volume":86683,"delay":0,"changeRate":-0.012316143895091268,"floatShares":8638900,"shares":14671186,"eps":-8.876818,"marketStatus":"Trading","change":-1.39,"latestTime":"09-10 11:21:24 EDT","open":109.23,"high":113.949,"low":107.22,"amount":9607527.6416,"amplitude":0.059623,"askPrice":112.17,"askSize":11,"bidPrice":111.04,"bidSize":54,"shortable":3,"etf":0,"ttmEps":-8.876818,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":112.86,"preHourTrading":{"tag":"盘前","latestPrice":113.2595,"preClose":112.86,"latestTime":"09:27 EDT","volume":1,"amount":113.2595,"timestamp":1789046870304,"change":0.3995,"changeRate":0.00354,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":112,"preClose":112.86,"latestTime":"19:39 EDT","volume":23147,"amount":2611191.38,"timestamp":1788997199516,"change":-0.86,"changeRate":-0.00762,"amplitude":0.009215},"volumeRatio":0.521772,"impliedVol":0.9513,"impliedVolPercentile":0.3506},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":8638900,"roa":"-43.61%","roe":"-1773.60%","lyrEps":-9.043391,"volumeRatio":0.521772,"shares":14671186,"dividePrice":0,"high":113.949,"amplitude":0.059623,"preClose":112.86,"low":107.22,"week52Low":26.19,"pbRate":"-30.87","week52High":155.29,"institutionHeld":0,"latestPrice":111.47,"committee":0.661538,"eps":-8.876818,"divideRate":0,"volume":86683,"delay":0,"ttmEps":-8.876818,"open":109.23,"prevYearClose":79,"prevWeekClose":121.17,"prevMonthClose":126.7,"prevQuarterClose":94.75,"fiveDayClose":124.97,"twentyDayClose":98.36,"sixtyDayClose":93.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"INBX","fiscalQuarterEnding":"2026/06","expectedEps":-2.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-14","symbol":"INBX","fiscalQuarterEnding":"2026/03","expectedEps":-2.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.15},{"market":"US","date":"2026-03-19","symbol":"INBX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-2.11},{"market":"US","date":"2025-11-14","symbol":"INBX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-2.28},{"market":"US","date":"2025-08-13","symbol":"INBX","fiscalQuarterEnding":"2025/06","expectedEps":-2.92,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1787630400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2026-09-09","current":-12.557428,"percent":0.107755,"low":-22.314917,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"high":0.20643,"avg":-6.69301,"sd":5.145655,"marketCap":1682817244},"quantilePoints":[{"date":"2021-09-10","current":-16.530107,"twenty":-15.521886,"median":-12.271925,"eighty":-8.940445,"marketCap":1291745234},{"date":"2021-09-17","current":-17.950853,"twenty":-15.909368,"median":-12.434577,"eighty":-8.944079,"marketCap":1402769392},{"date":"2021-09-24","current":-17.829629,"twenty":-16.480889,"median":-12.612787,"eighty":-8.953333,"marketCap":1393296341},{"date":"2021-10-01","current":-15.730029,"twenty":-16.490733,"median":-12.663254,"eighty":-8.96336,"marketCap":1229223097},{"date":"2021-10-08","current":-12.97097,"twenty":-16.480889,"median":-12.827884,"eighty":-9.035825,"marketCap":1013616457},{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-25","current":0.102764,"twenty":-12.551715,"median":-8.025451,"eighty":-4.412256,"marketCap":173421329},{"date":"2025-05-02","current":0.10568,"twenty":-12.478937,"median":-8.000315,"eighty":-4.235537,"marketCap":178343137},{"date":"2025-05-09","current":0.096588,"twenty":-12.439597,"median":-7.991946,"eighty":-4.089773,"marketCap":162998679},{"date":"2025-05-16","current":0.100989,"twenty":-12.434577,"median":-7.97539,"eighty":-4.044568,"marketCap":174000366},{"date":"2025-05-23","current":0.105357,"twenty":-12.381901,"median":-7.908838,"eighty":-3.993853,"marketCap":181527836},{"date":"2025-05-30","current":0.115524,"twenty":-12.32239,"median":-7.842802,"eighty":-3.849968,"marketCap":199043680},{"date":"2025-06-06","current":0.108298,"twenty":-12.28145,"median":-7.820969,"eighty":-3.684995,"marketCap":186594402},{"date":"2025-06-13","current":0.120397,"twenty":-12.27012,"median":-7.741529,"eighty":-1.480952,"marketCap":207439704},{"date":"2025-06-20","current":0.12779,"twenty":-12.256868,"median":-7.679625,"eighty":-1.456331,"marketCap":220178499},{"date":"2025-06-27","current":0.124261,"twenty":-12.215704,"median":-7.603614,"eighty":-1.340788,"marketCap":214098620},{"date":"2025-07-03","current":0.1372,"twenty":-12.181568,"median":-7.503213,"eighty":-1.260418,"marketCap":236391512},{"date":"2025-07-11","current":0.176268,"twenty":-12.147999,"median":-7.450386,"eighty":-1.219442,"marketCap":303704465},{"date":"2025-07-18","current":0.198448,"twenty":-12.097216,"median":-7.41608,"eighty":-1.173893,"marketCap":341920852},{"date":"2025-07-25","current":0.193827,"twenty":-12.055911,"median":-7.368888,"eighty":-1.136258,"marketCap":333959105},{"date":"2025-08-01","current":0.184165,"twenty":-12.0097,"median":-7.300695,"eighty":-1.006646,"marketCap":317311815},{"date":"2025-08-08","current":0.179293,"twenty":-11.932996,"median":-7.27517,"eighty":0.093431,"marketCap":308915791},{"date":"2025-08-15","current":-2.118471,"twenty":-11.899726,"median":-7.210926,"eighty":0.095163,"marketCap":346780978},{"date":"2025-08-22","current":-2.137939,"twenty":-11.899726,"median":-7.188912,"eighty":0.095163,"marketCap":349967771},{"date":"2025-08-29","current":-2.467125,"twenty":-11.899726,"median":-7.117001,"eighty":0.095163,"marketCap":403853537},{"date":"2025-09-05","current":-2.452966,"twenty":-11.910821,"median":-7.080055,"eighty":0.095189,"marketCap":401535870},{"date":"2025-09-12","current":-2.517565,"twenty":-11.899726,"median":-7.052928,"eighty":0.095163,"marketCap":412110227},{"date":"2025-09-19","current":-2.358281,"twenty":-11.899726,"median":-7.022207,"eighty":0.095163,"marketCap":386036469},{"date":"2025-09-26","current":-2.817991,"twenty":-11.899726,"median":-6.994363,"eighty":0.095163,"marketCap":461288231},{"date":"2025-10-03","current":-3.102932,"twenty":-11.899726,"median":-6.957161,"eighty":0.095163,"marketCap":507931287},{"date":"2025-10-10","current":-3.09718,"twenty":-11.899726,"median":-6.916619,"eighty":0.095163,"marketCap":506989735},{"date":"2025-10-17","current":-3.238323,"twenty":-11.899726,"median":-6.888862,"eighty":0.095163,"marketCap":530093981},{"date":"2025-10-24","current":-2.5096,"twenty":-11.899726,"median":-6.871444,"eighty":0.095163,"marketCap":410806539},{"date":"2025-10-31","current":-6.947417,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1137250402},{"date":"2025-11-07","current":-7.166874,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1173174246},{"date":"2025-11-14","current":-6.603187,"twenty":-11.899726,"median":-6.865553,"eighty":0.095163,"marketCap":1080902115},{"date":"2025-11-21","current":-7.487278,"twenty":-11.861937,"median":-6.865553,"eighty":0.095163,"marketCap":1161172041},{"date":"2025-11-28","current":-7.88865,"twenty":-11.742377,"median":-6.865553,"eighty":0.095163,"marketCap":1223419240},{"date":"2025-12-05","current":-8.197182,"twenty":-11.617777,"median":-6.865553,"eighty":0.095163,"marketCap":1271268138},{"date":"2025-12-12","current":-7.709533,"twenty":-11.403957,"median":-6.865553,"eighty":0.095163,"marketCap":1195640700},{"date":"2025-12-19","current":-8.001185,"twenty":-11.337354,"median":-6.865553,"eighty":0.095163,"marketCap":1240871726},{"date":"2025-12-26","current":-7.536043,"twenty":-11.289254,"median":-6.865553,"eighty":0.095163,"marketCap":1168734785},{"date":"2026-01-02","current":-7.408504,"twenty":-11.181733,"median":-6.865553,"eighty":0.095163,"marketCap":1148955302},{"date":"2026-01-09","current":-7.052146,"twenty":-11.074324,"median":-6.865553,"eighty":0.095163,"marketCap":1093689097},{"date":"2026-01-16","current":-6.733299,"twenty":-10.974222,"median":-6.860645,"eighty":0.095163,"marketCap":1044240388},{"date":"2026-01-23","current":-7.454456,"twenty":-10.939172,"median":-6.859408,"eighty":0.095163,"marketCap":1156081733},{"date":"2026-01-30","current":-6.804571,"twenty":-10.880889,"median":-6.848864,"eighty":0.095163,"marketCap":1055293629},{"date":"2026-02-06","current":-7.645764,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"marketCap":1185750959},{"date":"2026-02-13","current":-7.700156,"twenty":-10.655341,"median":-6.848864,"eighty":0.095163,"marketCap":1194186327},{"date":"2026-02-20","current":-7.603564,"twenty":-10.601716,"median":-6.848864,"eighty":0.095163,"marketCap":1179206277},{"date":"2026-02-27","current":-7.242516,"twenty":-10.568541,"median":-6.848864,"eighty":0.095163,"marketCap":1123212885},{"date":"2026-03-06","current":-6.626391,"twenty":-10.505783,"median":-6.845284,"eighty":0.095163,"marketCap":1027660527},{"date":"2026-03-13","current":-6.498853,"twenty":-10.428161,"median":-6.829185,"eighty":0.095163,"marketCap":1007881043},{"date":"2026-03-20","current":-6.765617,"twenty":-10.386411,"median":-6.812729,"eighty":0.095163,"marketCap":947558425},{"date":"2026-03-27","current":-6.861568,"twenty":-10.343704,"median":-6.806916,"eighty":0.095163,"marketCap":960996898},{"date":"2026-04-02","current":-6.99298,"twenty":-10.343704,"median":-6.799786,"eighty":0.095163,"marketCap":979401763},{"date":"2026-04-10","current":-7.900346,"twenty":-10.298288,"median":-6.792174,"eighty":0.095163,"marketCap":1106482977},{"date":"2026-04-17","current":-8.667957,"twenty":-10.251785,"median":-6.792174,"eighty":0.095163,"marketCap":1213990761},{"date":"2026-04-24","current":-12.508099,"twenty":-10.281908,"median":-6.792174,"eighty":0.095163,"marketCap":1751821827},{"date":"2026-05-01","current":-13.476187,"twenty":-10.362548,"median":-6.792174,"eighty":0.095163,"marketCap":1887407424},{"date":"2026-05-08","current":-12.987035,"twenty":-10.481137,"median":-6.792174,"eighty":0.095163,"marketCap":1818899252},{"date":"2026-05-15","current":-13.09064,"twenty":-10.541397,"median":-6.792174,"eighty":0.095163,"marketCap":1704204965},{"date":"2026-05-22","current":-12.460675,"twenty":-10.629123,"median":-6.792174,"eighty":0.095163,"marketCap":1622193036},{"date":"2026-05-29","current":-11.718016,"twenty":-10.669392,"median":-6.788501,"eighty":0.095189,"marketCap":1525509920},{"date":"2026-06-05","current":-10.28341,"twenty":-10.673287,"median":-6.792174,"eighty":0.095163,"marketCap":1338745722},{"date":"2026-06-12","current":-10.541481,"twenty":-10.587946,"median":-6.792174,"eighty":0.095163,"marketCap":1372342738},{"date":"2026-06-18","current":-10.61586,"twenty":-10.547355,"median":-6.792174,"eighty":0.095163,"marketCap":1382025721},{"date":"2026-06-26","current":-10.740951,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1398310737},{"date":"2026-07-02","current":-10.699254,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1392882398},{"date":"2026-07-10","current":-11.703366,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1523602666},{"date":"2026-07-17","current":-10.037735,"twenty":-10.494482,"median":-6.788501,"eighty":0.095189,"marketCap":1306762537},{"date":"2026-07-24","current":-9.579067,"twenty":-10.450596,"median":-6.788501,"eighty":0.095189,"marketCap":1247050810},{"date":"2026-07-31","current":-9.548639,"twenty":-10.386526,"median":-6.78817,"eighty":0.095215,"marketCap":1243089589},{"date":"2026-08-07","current":-9.668096,"twenty":-10.28924,"median":-6.78817,"eighty":0.095215,"marketCap":1258641046},{"date":"2026-08-14","current":-10.967164,"twenty":-10.28341,"median":-6.78817,"eighty":0.095215,"marketCap":1427760196},{"date":"2026-08-21","current":-10.560468,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1459255989},{"date":"2026-08-28","current":-13.199786,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1823959603},{"date":"2026-09-04","current":-13.021914,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1799381111},{"date":"2026-09-09","current":-12.178355,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1682817244}],"updateTime":1789053684824},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666377221","title":"Inhibrx Biosciences reports strong Phase 2 INBRX-106 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377221","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377221?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:39","pubTimestamp":1788899956,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc ( ($INBX) ) has provided an announcement. On September 8, 2026, Inhibrx Biosciences reported primary endpoint data from the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-strong-phase-2-inbrx-106-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-strong-phase-2-inbrx-106-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372032","title":"Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372032","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372032?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Inhibrx CEO Mark Lappe reports acquisition of 25,000 common shares worth $2.59 millionInhibrx Biosciences CEO Mark Lappe reported open-market purchases totaling 25,000 common shares at weighted-averag","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2Cmjwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibrx CEO Mark Lappe Reports Acquisition of 25,000 Common Shares Worth $2.59 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937657","title":"Inhibrx Biosciences Shares Fall 22% After Co Releases Data from Mid-Stage Study of Its Experimental Combination Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937657?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:17","pubTimestamp":1788877020,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N45015Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375756","title":"Analysts Offer Insights on NA Companies: First Horizon (FHN) and Inhibrx Biosciences Inc (INBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375756?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:40","pubTimestamp":1788874808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on First Horizon (FHN) and Inhibrx Biosciences Inc (INBX) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-first-horizon-fhn-and-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-first-horizon-fhn-and-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4589","BK4139","BK4141","FHN","INBX","BK4211","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665780933","title":"Inhibrx Biosciences Says Cancer Combination Therapy Shows Improved Response in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665780933","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665780933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:50","pubTimestamp":1788871810,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences'  experimental cancer drug, INBRX-106, nearly doubled the response rate when combined with pembrolizumab in a phase 2 trial for head and neck cancer, the drugmaker said Tuesday.The combination produced a confirmed objective response rate of 48.3%, compared with 26.5% for pembrolizumab alone, Inhibrx said.Complete responses occurred in 13.8% of patients receiving the combination, while none were reported in the control group, with median progression-free survival of 9.6 months versus 4.9 months, respectively, the company said.The benefit was stronger in patients with HPV-positive disease, with an 80% confirmed objective response rate for the combination versus 33.3% for pembrolizumab alone, the company said.Inhibrx said it plans to add about 50 HPV-positive oropharyngeal cancer patients to the phase 2 trial and then discuss a potential phase 3 confirmatory study with the US Food and Drug Administration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665270773","title":"Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2665270773","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665270773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:57","pubTimestamp":1788868620,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences reported positive results from a Phase 2 study of a potential treatment for metastatic or unresectable recurrent head and neck squamous cell carcinoma.The clinical-stage biopharmaceutical company said Tuesday its INBRX-106 drug in combination with pembrolizumab demonstrated a confirmed objective response rate of 48% compared with about 27% for pembrolizumab alone. About 14% of patients in the combination arm achieved a complete response, compared with no complete responses in the control arm, the company said.Additionally, median progression-free survival stood at 9.6 months for the drug combination versus 4.9 months for pembrolizumab alone as of the data cutoff.The drug combination showed particular efficacy in patients with HPV+ disease, which has prompted the company to expand the study by about 50 additional HPV+ oropharyngeal squamous cell carcinoma patients as it eyes a potential accelerated regulatory pathway.The results \"give us a strong rationale to expand ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibrx Biosciences Reports Positive Study Results for Squamous Cell Carcinoma Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327604","title":"Inhibrx Says Phase 2 Trial Shows INBRX-106 Plus Pembrolizumab Lifts Response Rate to 48.3% in HNSCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327604","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327604?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:31","pubTimestamp":1788867093,"startTime":"0","endTime":"0","summary":"Inhibrx says Phase 2 trial shows INBRX-106 plus pembrolizumab lifts response rate to 48.3% in HNSCCInhibrx reported primary endpoint results from a randomized Phase 2 HexAgon study of INBRX-106 with p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2090dK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665981327","title":"Inhibrx Biosciences: Currently Conducting Phase 1/2 Study of Inbrx-106 in Perioperative Setting of Nsclc, with Initial Results Targeted by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2665981327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665981327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665648327","title":"Inhibrx Biosciences Inc: Evaluating Potential of Inbrx-106 in Other Highly Immunogenic Tumor Types","url":"https://stock-news.laohu8.com/highlight/detail?id=2665648327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665648327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432763","title":"Inhibrx Biosciences - to Expand Phase 2 Study by 50 Hpv+ Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432763","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432763?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332768","title":"Inhibrx Biosciences - Inbrx-106 Plus Pembrolizumab Achieves 48.3% Corr and 72.4% Six-Month Pfs Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332768?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327647","title":"Inhibrx Biosciences Inc: Also Plans to Explore Potential of Inbrx-106 in Combination with Therapeutic Cancer Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327647?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665275703","title":"Inhibrx's Inbrx-106 Nearly Doubles Response Rate and Achieves Interim Median Pfs of 9.6 Months in Phase 2 Hnscc Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665275703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665275703?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5886QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665632734","title":"NASDAQ Trade Halt Halt News Pending at 07:25 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2665632734","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665632734?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:25","pubTimestamp":1788866700,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:25 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nAQN2MICOY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665535914","title":"Inhibrx Schedules Sept. 8 Webcast to Release Phase 2 INBRX-106 First-Line HNSCC Study Endpoint Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535914","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665535914?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:00","pubTimestamp":1788552022,"startTime":"0","endTime":"0","summary":"Inhibrx schedules Sept. 8 webcast to release Phase 2 INBRX-106 first-line HNSCC study endpoint resultsInhibrx scheduled a Sept. 8 webcast to present primary endpoint results from the Phase 2 portion o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8WKz46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278582","title":"Inhibrx Biosciences Price Target Announced at $245.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278582","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278582?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INBX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220881","title":"Inhibrx Biosciences, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $245","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661220881?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566121,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nAZN4TFZ0I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218157","title":"Inhibrx Biosciences (INBX) Earnings Put Its Valuation Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218157","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218157?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:25","pubTimestamp":1787347516,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences (INBX) is back in focus after reporting second quarter 2026 results, with a quarterly net loss of US$36.65 million and a six month net loss of US$70.09 million.\nSee our latest analysis for Inhibrx Biosciences.\nDespite the wider loss this quarter, Inhibrx Biosciences shares have climbed strongly over 2026, with a year to date share price return of 32.13% and a very large 1 year total shareholder return of 296.60%. Recent trading has been choppy, with the share price down...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inbx/inhibrx-biosciences/news/inhibrx-biosciences-inbx-earnings-put-its-valuation-back-in","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inbx/inhibrx-biosciences/news/inhibrx-biosciences-inbx-earnings-put-its-valuation-back-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659812584","title":"Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2659812584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659812584?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:15","pubTimestamp":1786727748,"startTime":"0","endTime":"0","summary":"In a report released today, Oliver McCammon from LifeSci Capital maintained a Buy rating on Inhibrx Biosciences Inc, with a price target of $230.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-inhibrx-ahead-of-key-inbrx-106-phase-2-readout-230-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-inhibrx-ahead-of-key-inbrx-106-phase-2-readout-230-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659012865","title":"Inhibrx Falls on Wider-than-Expected Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2659012865","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659012865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:47","pubTimestamp":1786722425,"startTime":"0","endTime":"0","summary":"BUZZ-Inhibrx falls on wider-than-expected quarterly loss** Shares of drug developer Inhibrx BiosciencesINBX.Ofall 8.2% to $89.09** Co reports Q2 net loss of $36.7 million vs analysts' average estimate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4N44B114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":98,"code":"91000000","status":"200"}]}}